Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease.
Hastings
T G
TG
University of Pittsburgh, Department of Neurology, Pennsylvania 15260, USA.
Lewis
D A
DA
Zigmond
M J
MJ
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D002396:Catechols / Q000378:metabolism; D003545:Cysteine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005609:Free Radicals / Q000378:metabolism; D006651:Histocytochemistry; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced / Q000473:pathology; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000378:metabolism*; D011485:Protein Binding; D011809:Quinones / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D002396:Catechols; D005609:Free Radicals; D011809:Quinones; D015102:3,4-Dihydroxyphenylacetic Acid; D003545:Cysteine; D004298:Dopamine